EP Patent

EP1396499A3 — Process for solubilizing glucagon-like peptide 1 (GLP-1) compounds

Assigned to Eli Lilly and Co · Expires 2004-12-29 · 21y expired

What this patent protects

Patent listed against Ozempic.

Drugs covered by this patent

Patent Metadata

Patent number
EP1396499A3
Jurisdiction
EP
Classification
—
Expires
2004-12-29
Drug substance claim
No
Drug product claim
No
Assignee
Eli Lilly and Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.